These observations, which are remarkably similar to the altered chromatin state also involving KDM5A observed in drug-tolerant lung cancer cells during their acute response to chemotherapeutic drugs and tyrosine kinase inhibitors [50], suggest that the loss of tumorigenicity in chronic drug-selected Du145 cells is ‘transient’ and reversible. The gene discussed is KDM5A; the disease is lung cancer.